Toggle Main Menu Toggle Search

Open Access padlockePrints

Therapeutic Possibilities in the Autosomal Recessive Limb-Girdle Muscular Dystrophies

Lookup NU author(s): Professor Volker StraubORCiD, Emerita Professor Katherine Bushby


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Fourteen years ago, the first disease-causing mutation in a form of autosomal recessive limb-girdle muscular dystrophy was reported. Since then the number of genes has been extended to at least 14 and the phenotypic spectrum has been broadened. The generation of mouse models helped to improve our understanding of the pathogenesis of the disease and also served to study therapeutic possibilities. All autosomal recessive limb-girdle muscular dystrophies are rare diseases, which is one reason why there have been so very few controlled clinical trials. Other reasons are insufficient natural history data and the lack of standardized assessment criteria and validated outcome measures. Currently, therapeutic possibilities are mainly restricted to symptomatic treatment and the treatment of disease complications. On the other hand, new efforts in translational research and the development of molecular therapeutic approaches suggest that more promising clinical trials will be carried out in autosomal recessive limb-girdle muscular dystrophy in the next several years. © 2008 The American Society for Experimental NeuroTherapeutics, Inc.

Publication metadata

Author(s): Straub VW, Bushby KMD

Publication type: Article

Publication status: Published

Journal: Neurotherapeutics

Year: 2008

Volume: 5

Issue: 4

Pages: 619-626

Print publication date: 01/10/2008

ISSN (print): 1933-7213

ISSN (electronic): 1545-5351

Publisher: Elsevier


DOI: 10.1016/j.nurt.2008.08.003


Altmetrics provided by Altmetric